chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Received 2/16 had sore arm that day starting wishing a few hours. 2/17 had a sore throat that lasted several,days and still today isn?t perfect 2/23.  Thursday around 8:30 pm I noticed a full body lumpy hive type of rash.  It wasn?t really itchy so I?m not betta in exactly when it started.  I took Benadryl at time of seeing it and contacted my doctor. I had a virtual visit and they prescribed prednisone for 5 days which I finish today.  The rash lessened by Friday around 6pm and was mostly gone by Saturday when I woke up.  I am having allergy testing and taking Claritin daily as my throat still at times feels itchy.  I did finish an new antibiotic the morning of the vaccine.
This spontaneous report was received from a other health professional refers to a 21 month old child with unknown gender. No pertinent medical history was reported. On 12-NOV-2014, the patient was vaccinated with an expired dose of pediatric VAQTA (lot # was 1697AA and expiration date was 22-Sep-2014) (strength, dose, route, were not reported). Concomitant therapy was not reported. No adverse effects were reported. Additional information has been requested.
PT COMPLAINS ON CONSTANT PAIN AT THE SITE OF SHOT. SHOT WAS GIVEN ON 10/25/20, HE STILL FILLS THE PAIN.
After the first dose heart palpitations  worsened, muscle pain, fatigue, chest pain (sharp pains), shortness of breath, pain and numbness  in legs.
ACUTE HYPOXEMIC RESPIRATORY FAILURE CHRONIC HYPOXEMIC RESPIRATORY FAILURE HYPOXIA 10/3/2022,  10/15/2022,  11/11/2022,  2/20/2023  --  RECURRENCE OF HOSPITALIZATION WITH SAME SYMPTOMS
Shaking chills, cold extremities, livedo reticularis on the thighs, lasted about 2 hours on the night of vaccination. Treated with tylenol. The next afternoon, he had documented ventricular tachycardia and his defibrillator fired 4 times in 1 hour, requiring EMS activation and hospitalization. His last ICD firing prior to that (only once)  was in August 2020 and prior to that more than 2 years of no ICD firing.
Malaise, vertigo, nausea, vomiting, aching knee and hip joints bilaterally until noon September 30th, 2017.
Extremely high blood pressure - chest constrictions - difficulty breathing.  Started Blood pressure medicine June 25, was not sufficient so added diuretic July 10, drastic shifts in blood pressure level so added additional blood pressure medicine to the other two on August 5. Now steady pressure in a normal zone
No other side effects or concerns; Patient received a dose of expired PROQUAD; This spontaneous report was received from a other referring to a patient of unreported age and gender. The patient's relevant medical history and concomitant medications were not provided.   On 16-DEC-2021 the patient was vaccinated with expired measles, mumps, rubella and varicella (Oka-Merck) virus vaccine live (PROQUAD) as prophylaxis (expired product administered) (lot number reported as S003861, expiration date-08-AUG-2020; dose, dose number, vaccination scheme, route of administration, and anatomical location of vaccination were not reported).      At the time of reporting, it was reported that no other side effects or concerns (No adverse event).
Severe headaches, tiredness, fatigue, difficulty walking w/o assistance, lightheadedness, hallucinations that disappeared 3 nights after the vaccination.
Information has been received from a pharmacist concerning a female with unspecified drug reactions/allergies and medical history, who "a couple months ago" (approximately April 2009), was vaccinated with GARDASIL (dose, route and lot number unspecified). The pharmacist stated "A patient developed tonic-clonic movements directly after being given a dose of GARDASIL". At the time of this report the outcome of the patient was recovered (date unspecified). The patient sought unspecified medical attention. Additional information has been requested.
doses administered after more than 1 temperature excursion; doses administered after more than 1 temperature excursion; This spontaneous case was reported by an other health care professional and describes the occurrence of POOR QUALITY PRODUCT ADMINISTERED (doses administered after more than 1 temperature excursion) and PRODUCT TEMPERATURE EXCURSION ISSUE (doses administered after more than 1 temperature excursion) in a 66-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 29-Apr-2021 at 4:08 PM, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .5 milliliter. On 29-Apr-2021 at 4:08 PM, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (doses administered after more than 1 temperature excursion). On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (doses administered after more than 1 temperature excursion). At the time of the report, POOR QUALITY PRODUCT ADMINISTERED (doses administered after more than 1 temperature excursion) and PRODUCT TEMPERATURE EXCURSION ISSUE (doses administered after more than 1 temperature excursion) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   The patient age was reported as 66.03 years.  No concomitant product use was reported.   It was reported that unknown number of patients were administered with vaccines that experienced more than 1 temperature excursion during 33 weeks in 2021. The HCP explained that each time a vial was put into a cooler, there was a period of time of 1 hour or 1 hour and a half approximately, when the temperature data logger registered 34 or 35 degree F.  Vial was stored on cooler 1, on 29-Apr-2021, excursion duration at 9 am 36, at 10 am 33, at 11 am 44, at 12 am 45, at 1 pm 45, at 2 pm 44, at 3 pm 45, at 4 pm 44.  On 29-Apr-2021, excursion time at 10 am temperature was 33, total doses given for the day was 201, condition of vaccine prior to vaccination was not frozen, vaccine was moved to fridge on 19-Apr-2021, vial was moved to clinic on 29-Apr-2021. 5 vial was moved to clinic. Vaccine BUD date was 19-May-2021.  Vials only punctured right before administration.  No treatment information was provided.
PT FELT LIGHT HEADED AND STATED THEY HAD TUNNEL VISION. PT LAYED HIMSELF ON THE FLOOR WITH HIS FEET ELEVATED ON A BENCH. PHARMACIST GAVE HIM WATER AND TOOK HIS BP, WHICH WAS LOW.  AFTER ABOUT 10 MIN PT FELT BETTER AND SAT UP. PT REMAINED FOR ABOUT 15 MORE MIN AND THEN LEFT NOT NEEDING FURTHER ASSISTANCE.
Soreness in her arm; Soreness in her body; Pain and throbbing inside her arm; This spontaneous case was reported by an other health care professional and describes the occurrence of PAIN IN EXTREMITY (Soreness in her arm), PAIN (Soreness in her body) and PAIN (Pain and throbbing inside her arm) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-May-2021, the patient experienced PAIN (Pain and throbbing inside her arm). On 06-May-2021, the patient experienced PAIN (Soreness in her body). On an unknown date, the patient experienced PAIN IN EXTREMITY (Soreness in her arm). At the time of the report, PAIN IN EXTREMITY (Soreness in her arm) and PAIN (Pain and throbbing inside her arm) outcome was unknown and PAIN (Soreness in her body) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported.  No treatment information was provided.
Muscle weakness, extreme fatigue, inflammation of joints, painful joints, neuropathy in feet and hands. Consulted with family physician, and as pain and inflammation increased, a rheumatologist and neurologist were sought.  Physical therapy has been attempted with no results. EMG of muscles and nerves has been completed with good results, yet the inflammation, joint swelling, and pain continue. A muscle biopsy has been scheduled for February 17. Rheumatologist recommended I reach out to the CDC to create awareness of these symptoms and this health journey. I was in good health before the vaccine, except an occasional kidney stone due to a congenital kidney defect. Some days, I struggle to walk due to the neuropathy in my feet. Strangely enough, I received my vaccine in my left arm, and my most significant muscle weakness is in none other than my left arm. The scheduled muscle biopsy specimen will be taken from my left arm. My hands and fingers are swollen, ache, and my work has been impacted. I expect these symptoms are rare, but agree with Dr. that the CDC should be notified about my case.
Patient received expired vaccine. Office calling Pfizer to get stability data. Will revaccinate if recommended.
On 8/14/08 - family called & said her legs were weak - hard to walk - sore throat - headache - dizziness - loss of voice - she started with dizziness on 8/13/08.  Sent to hospital on 8-14-08.
2nd dose of the vaccine on 11Feb2021 but tested positive today for COVID/tested positive for covid virus; 2nd dose of the vaccine on 11Feb2021 but tested positive today for COVID/tested positive for covid virus; This is a spontaneous report from Pfizer sponsored program COVAX US Support. A contactable consumer reported that a male patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19, Formulation: Solution for injection, Batch/Lot number was not reported), via an unspecified route of administration on 11Feb2021 as a single dose for COVID-19 immunization.The patient medical history and concomitant medications were not reported. The patient historical vaccine includes BNT162B2 (1st dose) for COVID immunization. It was reported that patient had 2nd dose of covid vaccine 11Feb2021. Had tested positive for covid virus today. Also received infusion after testing positive. Wants to know shouldn't they have waited to give dad infusion. The patient underwent lab tests and procedures which included sars-cov-2 antibody test: positive on 16Feb2021 tested positive today for COVID. The action taken in response to the event(s) for bnt162b2 was not applicable. Therapeutic measures were taken as a result of event. The outcome of the events was unknown.  Information on the lot/batch number has been requested.
Heavy sinus drainage with severe coughing and wheezing. Only 10% of coughs result in producing mucus to spit.
2nd dose given to patient who was under the age of 12, mother lied about patients birthdate stating it was 6/5/2008 not the patients actual birthdate 6/5/2010.
Pt. states after receiving the Moderna 1st shot 12/31/2020, started experiencing 01/03/2021 symptoms achey, confusion, nauseous, severe left-sided chest pain (up the left side to neck), headache, irregular heart beat, HBP, Follow-Up with Cardiologist, swelling of the face, exhaustion every 10 to 12 days. ER 01/03/2021
fever; trouble breathing; he felt hot; This case was reported by a consumer via call center representative and described the occurrence of difficulty breathing in a 76-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   On 1st December 2021, the patient received the 2nd dose of Shingrix. On 2nd December 2021, 1 days after receiving Shingrix, the patient experienced fever. In December 2021, the patient experienced difficulty breathing and feeling hot. The patient was treated with paracetamol (Tylenol). On an unknown date, the outcome of the difficulty breathing and fever were not recovered/not resolved and the outcome of the feeling hot was unknown.   It was unknown if the reporter considered the difficulty breathing, feeling hot and fever to be related to Shingrix.  Additional details were reported as follows: The case was reported by the patient. The patient received his 2nd dose of Shingrix day before reporting. The patient stated that he had trouble breathing last night and continues to do so on the day of reporting. The patient also stated that he felt hot a dsy before reporting and had a fever on the day of reporting. The patient took some Tylenol for the fever dose unknown. The reporter did not consent to follow up.
very sick; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of MALAISE (very sick) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced MALAISE (very sick). At the time of the report, MALAISE (very sick) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medications were not reported. Treatment details were not reported.
Laceration of foot; Wound infection; Vaccination site pain; Fever; Fatigue; This spontaneous case was reported by a consumer and describes the occurrence of SKIN LACERATION (Laceration of foot), WOUND INFECTION (Wound infection), VACCINATION SITE PAIN (Vaccination site pain), PYREXIA (Fever) and FATIGUE (Fatigue) in an elderly female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.    Co-suspect product included non-company product ADALIMUMAB (HUMIRA) for Crohn's disease.    No Medical History information was reported.   On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form On an unknown date, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form and third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. and ADALIMUMAB (HUMIRA) (Subcutaneous) Citrate free. On an unknown date, the patient experienced SKIN LACERATION (Laceration of foot), WOUND INFECTION (Wound infection), VACCINATION SITE PAIN (Vaccination site pain), PYREXIA (Fever) and FATIGUE (Fatigue). The patient was treated with BACITRACIN ZINC, POLYMYXIN B SULFATE (ANTIBIOTIC OINTMENT) at an unspecified dose and frequency; DOXYCYCLINE at an unspecified dose and frequency and MUPIROCIN at an unspecified dose and frequency. At the time of the report, SKIN LACERATION (Laceration of foot), WOUND INFECTION (Wound infection), VACCINATION SITE PAIN (Vaccination site pain), PYREXIA (Fever) and FATIGUE (Fatigue) had resolved.            No concomitant medications were reported. Patient was not enrolled in a COVID-19 Vaccine Trial. This case was identified as part of a retrospective clean-up activity where certain emails received in the Moderna mailbox were missed to be booked-in.
shingles; This spontaneous report was received from a lawyer regarding a case in litigation and refers to a female patient of unknown age. The patient's medical history, concurrent conditions and concomitant medications were not reported. On or about 31-MAR-2009, the patient was inoculated with zoster vaccine live (ZOSTAVAX) (exact dose, site and route of administration, lot# and expiration date were not reported) for the long-term prevention of shingles and/or zoster-related conditions, in a pharmacy by a pharmacist. Subsequent to the patient's zoster vaccine live (ZOSTAVAX) inoculation, she was treated by a physician for shingles. As a direct and proximate result of the patient's use of the zoster vaccine live (ZOSTAVAX) vaccine, the patient had and would continue suffer ongoing injuries, including but not limited to: mental and physical pain and suffering; medical care and treatment for these injuries; significant medical and related expenses as a result of these injuries, including but not limited to medical losses and costs include care for hospitalization, physician care, monitoring, treatment, medications, and supplies; diminished capacity for the enjoyment of life; diminished quality of life; increased risk of premature death, aggravation of preexisting conditions and activation of latent conditions; and other losses and damages; and would continue to suffer such losses, and damages in the future. The outcome of the event was not recovered. The relatedness between the event and zoster vaccine live (ZOSTAVAX) was related.
Proquad #1 given on 5/15/19 on 5/31 he had fever 102 degrees - went to urgent care and put on cefdinir - received 2 doses - then mom noticed a diffuse macular rash on face, trunk, extremities - the child was not having other symptoms - the rash was most consistent with mild exanthem or vaccine related rash not drug related rash
felt cold; has little appetite; sleep all day; injection site hard; vaccination site red; arm swollen at vaccination site; nauseous; fatigue; This spontaneous case was reported by an other caregiver and describes the occurrence of FEELING COLD (felt cold), DECREASED APPETITE (has little appetite), HYPERSOMNIA (sleep all day), VACCINATION SITE INDURATION (injection site hard) and VACCINATION SITE ERYTHEMA (vaccination site red) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 18-Jan-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Jan-2021, the patient experienced FEELING COLD (felt cold), DECREASED APPETITE (has little appetite), HYPERSOMNIA (sleep all day), VACCINATION SITE INDURATION (injection site hard), VACCINATION SITE ERYTHEMA (vaccination site red), VACCINATION SITE SWELLING (arm swollen at vaccination site), NAUSEA (nauseous) and FATIGUE (fatigue). At the time of the report, FEELING COLD (felt cold), DECREASED APPETITE (has little appetite), HYPERSOMNIA (sleep all day), VACCINATION SITE INDURATION (injection site hard), VACCINATION SITE ERYTHEMA (vaccination site red), VACCINATION SITE SWELLING (arm swollen at vaccination site), NAUSEA (nauseous) and FATIGUE (fatigue) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant details included various medications but no specific.. Treatment included Advil, Cayenne 2 capsules (probiotic) for warming up.
skin rashes and seemingly permanent discoloration because the hyper pigmentation spread across my neck and has gotten worse since being vaccinated. Prior to vaccination, none of these symptoms were present.
Started with chills next morning (Friday)  around 11, then body aches, fever 102.9.  Gave tylenol.  Had flu like symptoms, weak, tired was in bed until Saturday afternoon. Still tired on Sunday.  This is First dose received.
This is a spontaneous report from a non-contactable consumer reporting for himself. A 65-year-old male patient received PREVNAR 13, intramuscular in the left upper arm, on unspecified date in Sep2014 (reported as about 4 months before the report), at 0.5 ml single, for pneumonia prevention. Relevant medical history included ongoing enlarged prostate and ongoing idiopathic peripheral neuropathy. Concomitant medications included ongoing LYRICA capsule oral at 3 dosage forms daily for idiopathic peripheral neuropathy and ongoing tamsulosin capsule oral at 0.14 mg once a day for prostate enlargement. No other medications, medical conditions or vaccines were given on the same day as the PREVNAR 13 vaccination. On an unknown date in Sep2014, the patient experienced muscle pain in the bicep area/upper arm near the injection. The patient stated that it was pretty bad for a couple of weeks then got better, but it never went away. He added that he had not had any injury to the area and he had tried to stop using the arm. Additionally in Oct2014, the patient experienced left upper arm pain, from his left elbow up to his left shoulder. The pain persisted, but seemed to get a little better within a few weeks. The patient did not receive any treatment or require hospitalization due to the events. The clinical outcome of the events was not recovered. The patient stated that the muscle pain had not gone away and seemed to be permanent damage. Follow-up (02Feb2015): New information received from a contactable consumer reporting for himself included: patient's details, event "Left upper arm pain" added, vaccination date, site of administration updated, indication updated, medical history, concomitant medications. Follow up (24Feb2015): New information received from the same contactable consumer includes: concomitant medications (ongoing), reaction data, treatment (NO), and outcome (not recovered).
She had a sore arm; This spontaneous case was reported by an other health care professional and describes the occurrence of PAIN IN EXTREMITY (She had a sore arm) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 02-Nov-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-Nov-2021, the patient experienced PAIN IN EXTREMITY (She had a sore arm). At the time of the report, PAIN IN EXTREMITY (She had a sore arm) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant information was not provided. Treatment information was not provided.   This case was linked to MOD-2021-402933, MOD-2021-402946 (Patient Link).
Muscle aches, particularly neck; swollen lymph nodes left supraclavicular; headache; fatigue.  These symptoms lasted for approximately two weeks.
A day or so after taking the First Merdona immunization  1/6/21 developed warmth in rt arm with redness and some pain. Also noted burning on right side under rt arm and back. within 3 days of vaccine had a eruption of an rash on my back and over the weekend  1/11/21 developed vesicles under RT Brest
Headache, nausea starting 13 hours after vaccines with crying due to headache for two days, improving now at 72 hours post-vaccine.
arm was a little sore; Little rash, red dots on inside of bicep; This is a spontaneous report from a contactable consumer(Patient).  A 78-years-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 1via an unspecified route of administration, administered in Arm Left on 25Jan2021 16:35 as single dose for covid-19 immunisation. Medical history included mitral valve prolapse. The patient's concomitant medications were not reported. Had Pneumonia shot and yearly Flu shot. Had no reaction. Has no NDC/Lot/Exp to provide for Pneumonia and Flu shot. On 25Jan2021 in evening patient had a little rash on inside part of bicep. There were little red dots. It itched for a while. Next day was gone. Stated he was shrinking and provided height as 5 feet 11 inches. First time the dots were there it itched a little bit, next morning it was gone. Had no reaction to COVID-19 Vaccine. Had no fever, nothing else. Next day his arm was a little sore. Patient clarified rash and red dots occurred on both arms. Patient thought rash and red dots were something else like detergent or he didn't rinse soap off in the shower. his doctor didn't seem to think it was anything serious. No prior vaccinations within 4 weeks. Had a family medical history of diabetes runs in family, but most other people had that in their eighties and nineties.The outcome of the event little rash on inside part of bicep, little red dots was recovered on 26Jan2021 and for other it was unknown.